MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Pancreatic and Hepatic Oncology Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,444 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,444 works in the cohort · of 4,299,418page 20 of 49

Labels cover 7 of 2,444 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,444 of 2,444 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Analyses of updated overall survival (OS) and prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and CA 19-9 from the phase III MPACT study of <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) versus Gem for patients (pts) with metastatic pancreatic cancer (PC).
David Goldstein, Robert H. El-Maraghi, Pascal Hammel, Volker Heinemann, Volker Kunzmann, Javier Sastre +10 more
2014· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
affvenueaboutunlabeled
Survival in Cystic Neoplasms of the Pancreas
Ali Cadili, Amy Bazzerelli, Sipi Garg, Robert L. Bailey
2009· article· en· Canadian Journal of Gastroenterology· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
fundno affno abstractunlabeled
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
Constantinos P. Zambirinis, Elliot Levie, Susanna Nguy, Antonina Avanzi, Rocky Barilla, Yijie Xu +15 more
2015· article· en· The Journal of Cell Biology· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
A Day 14 Endpoint for Acute GVHD Clinical Trials
Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo‐Hiraldo +35 more
2024· article· en· Transplantation and Cellular Therapy· Medicine
machine prediction:candidate · noneconsensus · none
11
citations

How this was built: Screen · Findings · About